AC Immune Receives FDA Fast Track Designation for Anti-Alpha-synuclein Active Immunotherapy, ACI-7104, to Treat Early Parkinson’s Disease (PD)
Globe Newswire•11/08/2026•07:00 ET
0
Whiz Insights
Get started
Create a free account to read the full story.